Efficacy and Safety of Sitagliptin in Hispanic/Latino Patients with Type 2 Diabetes: A Pooled Analysis from Ten Randomized, Placebo-Controlled Phase 3 Clinical Trials.
Annaswamy RajiJianmin LongRaymond L H LamEdward A O'NeillSamuel S EngelPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2018)
Merck & Co., Inc., Kenilworth, NJ, USA.